A kind of pharmaceutical composition and pharmaceutical preparation for treating echinococcosis and application thereof

A kind of technology of hydatid disease and composition, applied in the field of medicine

Active Publication Date: 2019-08-30
QINGHAI UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

D-limonene is one of the main components of the Tibetan medicine Rhododendron azalea. It has anti-inflammatory, antibacterial, anti-tumor and other activities. It is currently used as a synergistic insecticide in gardens and agriculture. There is no literature report that it has a killing effect on internal parasites.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pharmaceutical composition and pharmaceutical preparation for treating echinococcosis and application thereof
  • A kind of pharmaceutical composition and pharmaceutical preparation for treating echinococcosis and application thereof
  • A kind of pharmaceutical composition and pharmaceutical preparation for treating echinococcosis and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] The present invention will be further described below in conjunction with specific examples, but this does not imply any limitation to the present invention.

[0026] 1. Experimental materials:

[0027] Eugenol: purity 99.5% (>99%), purchased from Shandong West Asia Chemical Co., Ltd.; - Limonene: Purity 99% (>98%), purchased from Chengdu Effa Biotech Co., Ltd.

[0028] Two, the preparation of pharmaceutical composition and pharmaceutical preparation for the treatment of echinococcosis:

[0029] Weigh 10g, 2g, and 10g of eugenol, β-asarone, and D-limonene, respectively, and include them with saturated β-cyclodextrin aqueous solution at a molar ratio of 1:1 at 60°C for 2 hours, and use a sand core funnel to pump Filter and dry. The final drug dose of each tablet is 4mg (all can be 2.5-5mg) eugenol, 0.8mg (all can be 0.5-1mg) β-asarone and 4mg (all can be 2.5-5mg) D-limonene, and then add auxiliary materials, Excipients include binders, disintegrants, excipients, etc....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an echinococcosis treating drug combination and preparation. The echinococcosis treating drug combination and preparation is prepared by taking eugenol, beta-asarone, D-limonene and beta-cyclodextrin as raw materials through the steps including, firstly, weighing out the eugenol, the beta-asarone and the D-limonene at a weight ratio of 5:1:5 for clathration in a beta-cyclodextrin saturated aqueous solution at a molar ratio of 1:1; secondly, suction-filtering the beta-cyclodextrin clathrate through a sand core funnel, and drying the filtered beta-cyclodextrin clathrate;thirdly, drying the raw drugs of the weight ratio of 5:1:5 as the main component, and then adding in auxiliary components for tableting to obtain tablets. The echinococcosis treating drug combinationand preparation can be applied to treating echinococcosis, and when combined with echinococcosis animal models on an in vivo level, can effectively reduce the number and weight of vesicae and kill protoscolex, thereby ensuring application to echinococcosis treatment; on an in vitro level, the echinococcosis treating drug combination and preparation can kill protoscolex into the vesicae of cystic echinococcosis, thereby determining application to surgical treatment of cystic echinococcosis.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition and pharmaceutical preparation for treating echinococcosis and applications thereof. Background technique [0002] Echinococcosis (Echinococcosis) is a parasitic disease that affects humans and animals. It is caused by the infection of Echinococcus tapeworms, so it is also called echinococcosis. It is mainly divided into cystic echinococcosis (CE) in my country. and Alveolar Echinocococosis (AE), which are caused by Echinococcus granulosus (E.g.) and Echinococcus multilocularis (E.m.) infection respectively. Echinococcus granulosus usually exists in mammals such as cattle, sheep, and pigs in the form of larvae, while Echinococcus multilocularis usually uses rodents such as mice as intermediate hosts, and humans are occasional hosts of Echinococcus granulosus / multilocularia . The intermediate host / accidental host is infected by ingesting eggs. The eg...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/015A61K31/085A61K31/09A61K9/28A61K47/69A61P33/10
Inventor 汤锋李润乐格日力樊海宁廖梦娇冯琳杨全宇
Owner QINGHAI UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap